Attendance for the 3rd Biennial International Symposium on Ocular Regeneration and the 5th Biennial International Symposium on AMD continues to climb each year, reflecting the high caliber of these meetings and the value they bring to their respective fields. Both events sparked great discussions and drew rave reviews from attendees, participants, and sponsors alike.
3rd Biennial International Symposium on Ocular Regeneration
Held on October 11, the 3rd Biennial International Symposium on Ocular Regeneration brought together leaders in the fields of ophthalmology, bioengineering, and regenerative medicine who aim to accelerate cures for blinding diseases. François Delori, PhD, a Harvard Medical School Professor of Ophthalmology and Senior Scientist at Schepens Eye Research Institute of Mass. Eye and Ear, presented the 2018 Ephraim Friedman Lecture, entitled “Fundus autofluorescence.”
Keynote speaker Robert Langer, ScD, the David H. Koch Institute Professor, Massachusetts Institute of Technology, presented a talk entitled “Biomaterials and biotechnology: from the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering.”
Budd Tucker, PhD, Associate Professor of Ophthalmology & Visual Sciences, University of Iowa, said the Ocular Regeneration symposium was an “outstanding meeting that continues to increase in size and interest each year.”
Organized by Harvard Ophthalmology Ocular Regenerative Medicine Institute Co-Directors Michael Young, PhD, and Demetrios Vavvas, MD, PhD, the event was sponsored by RxGen, Alcon, Biogen, Catalyst Biosciences, Gorin Foundation, ReNeuron, and the National Institutes of Health.
5th Biennial International Symposium on AMD
Held on October 12-13, the 5th Biennial International Symposium on AMD drew more than 200 clinicians, researchers, trainees, and industry representatives who discussed the latest advances in AMD research and the challenges that lay ahead.
Tea Soon Park, Research Associate, Johns Hopkins School of Medicine, said, “It was my first time attending the AMD symposium, and I found the program really interesting. I really liked the open discussion time, which allowed attendees to have informal conversations.”
Organized by Harvard Ophthalmology AMD Center of Excellence Co-Directors Patricia D’Amore, PhD, MBA; Ivana Kim, MD; and Deeba Husain, MD, the event was sponsored by the Broadhurst Foundation, Regeneron, Genentech, Biogen, Macular Degeneration Foundation, Heidelberg Engineering, American Macular Degeneration Foundation, Merck, and the National Institutes of Health.